[Molecular based targets and endometrial cancer]

Area of Science:

• Gynecology
• Oncology
• Molecular Biology

Background:

• Endometrial carcinoma spread, particularly in postmenopausal women, is a growing concern.
• Morphological methods and molecular profiling are advancing cancer diagnosis and prognosis.
• Targeted molecular therapies show promise for treating endometrial cancer.

Purpose of the Study:

• To review the role of molecular markers in endometrial carcinoma.
• To discuss their potential as prognostic indicators.
• To explore their utility in guiding targeted treatment strategies.

Main Methods:

• Literature review of recent advancements in endometrial carcinoma research.
• Analysis of morphological and molecular profiling techniques.
• Discussion of targeted therapy approaches and their efficacy.

Main Results:

• Molecular markers are increasingly recognized for their prognostic value in endometrial carcinoma.
• Targeted therapies based on molecular profiles demonstrate significant response rates in a proportion of cases.
• Further development of targeted treatments holds promise for improved patient outcomes.

Conclusions:

• Molecular markers are crucial for predicting endometrial carcinoma progression and patient prognosis.
• Targeted therapy represents a significant advancement in treating endometrial cancer.
• Continued research into molecular markers will likely lead to more effective and personalized treatment strategies.